Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2677 |
|
Actual shortage: | 255 (10%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2413 (90%) | |
Discontinuation Reports |
250 |
|
To be discontinued: | 3 (1%) | |
Discontinued: | 247 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
24 (9%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-CODEINE | 30MG | TABLET | Resolved | 2022-07-25 | 2022-12-22 | 165436 |
TEVA-LOPERAMIDE | 2MG | TABLET | Resolved | 2022-07-25 | 2022-10-01 | 165441 |
TEVA-CODEINE | 15MG | TABLET | Resolved | 2022-07-25 | 2022-12-22 | 165444 |
TEVA-EMTEC-30 | 30MG 300MG | TABLET | Resolved | 2022-07-25 | 2022-09-23 | 165450 |
ACT QUETIAPINE | 25MG | TABLET | Resolved | 2022-07-25 | 2023-01-19 | 165453 |
TEVA-FEBUXOSTAT | 80MG | TABLET | Resolved | 2022-07-25 | 2023-01-12 | 165456 |
TEVA-ATORVASTATIN | 10MG | TABLET | Resolved | 2022-08-18 | 2022-10-18 | 167153 |
ALERTEC | 100MG | TABLET | Resolved | 2022-08-18 | 2022-09-23 | 167165 |
TEVA-HALOPERIDOL | 0.5MG | TABLET | Resolved | 2022-08-18 | 2023-05-23 | 167168 |
TEVA-HALOPERIDOL | 10MG | TABLET | Resolved | 2022-08-18 | 2023-06-09 | 167171 |
TEVA-HALOPERIDOL | 1MG | TABLET | Resolved | 2022-08-18 | 2023-05-23 | 167174 |
TEVA-HALOPERIDOL | 2MG | TABLET | Resolved | 2022-08-18 | 2023-05-23 | 167177 |
TEVA-HALOPERIDOL | 2MG | TABLET | Resolved | 2022-08-18 | 2023-05-23 | 167179 |
TEVA-CLONIDINE | 0.025MG | TABLET | Resolved | 2022-08-18 | 2022-09-08 | 167191 |
TEVA-ZOLMITRIPTAN | 2.5MG | TABLET | Resolved | 2022-08-18 | 2023-04-28 | 167200 |
TEVA-BUPRENORPHINE/NALOXONE | 2MG 0.5MG | TABLET | Resolved | 2022-08-18 | 2022-12-02 | 167203 |
TEVA-SPIRONOLACTONE | 25MG | TABLET | Resolved | 2022-08-18 | 2023-04-28 | 167212 |
TEVA-PERINDOPRIL | 4MG | TABLET | Resolved | 2022-08-18 | 2022-10-01 | 167215 |
NOVO-GESIC | 325MG | TABLET | Resolved | 2022-08-18 | 2022-09-23 | 167229 |
TEVA-ABACAVIR/LAMIVUDINE | 300MG 600MG | TABLET | Resolved | 2022-08-18 | 2022-12-22 | 167237 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81337 | ||
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81344 | ||
HYDROCORTISONE SODIUM SUCCINATE INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81347 | ||
TEVA-RANITIDINE | Discontinued | 2020-02-13 | 2020-02-13 | 106136 | ||
TEVA-RANITIDINE | Discontinued | 2020-02-13 | 2020-02-13 | 106139 | ||
RATIO-SALBUTAMOL | Discontinued | 2020-02-13 | 2020-02-13 | 106151 | ||
GEMCITABINE FOR INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106155 | ||
EPTIFIBATIDE INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106170 | ||
LINEZOLID INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106173 | ||
EPTIFIBATIDE INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106176 |